Back to Search
Start Over
Ultimovacs ASA: Ultimovacs Expands High Dose Cohort Size in TENDU Phase I Prostate Cancer Trial after Safety Review
- Source :
- European Union News. August 19, 2022
- Publication Year :
- 2022
-
Abstract
- Oslo: Ultimovacs ASA has issued the following news release: Ultimovacs ASA ('Ultimovacs') (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, has completed treatment of three patients [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- European Union News
- Publication Type :
- News
- Accession number :
- edsgcl.714614304